Secondary hyperparathyroidism (SHPT) is widely prevalent in patients with chronic renal failure (CRF), characterized by parathyroid hyperplasia and elevated parathyroid hormone (PTH) [1, 2]. This evidence concerns the gene PTH and chronic kidney disease.